| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30085750 | HIV | ENSG00000161217.12 | protein_coding | PCYT1A | No | No | 5130 | P49585 |
| TVIS30059257 | HIV | ENSG00000161217.12 | protein_coding | PCYT1A | No | No | 5130 | P49585 |
| TVIS30059258 | HIV | ENSG00000161217.12 | protein_coding | PCYT1A | No | No | 5130 | P49585 |
| TVIS30059259 | HIV | ENSG00000161217.12 | protein_coding | PCYT1A | No | No | 5130 | P49585 |
| TVIS30059260 | HIV | ENSG00000161217.12 | protein_coding | PCYT1A | No | No | 5130 | P49585 |
| TVIS20056840 | HPV | ENSG00000161217.12 | protein_coding | PCYT1A | No | No | 5130 | P49585 |
| TVIS20057232 | HPV | ENSG00000161217.12 | protein_coding | PCYT1A | No | No | 5130 | P49585 |
| TVIS44012305 | HTLV-1 | ENSG00000161217.12 | protein_coding | PCYT1A | No | No | 5130 | P49585 |
| TVIS44032580 | HTLV-1 | ENSG00000161217.12 | protein_coding | PCYT1A | No | No | 5130 | P49585 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PCYT1A |
|---|---|
| DrugBank ID | DB00122 |
| Drug Name | Choline |
| Target ID | BE0000615 |
| UniProt ID | P49585 |
| Regulation Type | product of |
| PubMed IDs | 17184542; 17218027 |
| Citations | Enaw JO, Zhu H, Yang W, Lu W, Shaw GM, Lammer EJ, Finnell RH: CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population. BMC Med. 2006 Dec 21;4:36.@@Li L, She H, Yue SJ, Qin XQ, Guan CX, Liu HJ, Luo ZQ: Role of c-fos gene in vasoactive intestinal peptide promoted synthesis of pulmonary surfactant phospholipids. Regul Pept. 2007 May 3;140(3):117-24. Epub 2007 Jan 10. |
| Groups | Approved; Nutraceutical |
| Direct Classification | Cholines |
| SMILES | C[N+](C)(C)CCO |
| Pathways | Phosphatidylcholine Biosynthesis PC(14:0/20:0); Phosphatidylcholine Biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z)); Phosphatidylcholine Biosynthesis PC(15:0/20:3(8Z,11Z,14Z)); Phosphatidylcholine Biosynthesis PC(15:0/16:0); Phosphatidylcholine Biosynthesis PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z)); Phosphatidylcholine Biosynthesis PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:0); Phosphatidylcholine Biosynthesis PC(14:0/20:2(11Z,14Z)); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/22:2(13Z,16Z)); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/24:0); Phosphatidylcholine Biosynthesis PC(14:0/15:0); Phosphatidylcholine Biosynthesis PC(15:0/14:0); Phosphatidylcholine Biosynthesis PC(15:0/20:4(5Z,8Z,11Z,14Z)); Phosphatidylcholine Biosynthesis PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); Betaine Metabolism; Phosphatidylcholine Biosynthesis PC(14:0/20:1(11Z)); Phosphatidylcholine Biosynthesis PC(16:0/14:0); Phosphatidylcholine Biosynthesis PC(15:0/22:0); Phosphatidylcholine Biosynthesis PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z)); Phosphatidylcholine Biosynthesis PC(15:0/16:1(9Z)); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/14:0); Phosphatidylcholine Biosynthesis PC(15:0/20:1(11Z)); Phosphatidylcholine Biosynthesis PC(14:0/18:2(9Z,12Z)); Phosphatidylcholine Biosynthesis PC(14:0/14:0); Cystathionine beta-Synthase Deficiency; Phosphatidylcholine Biosynthesis PC(14:0/16:1(9Z)); Phosphatidylcholine Biosynthesis PC(15:0/18:0); Sarcosine Oncometabolite Pathway; Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:3(9Z,12Z,15Z)) |
| PharmGKB | PA448976 |
| ChEMBL | CHEMBL920 |
